Pharmaceuticals

Octreotide Market Size and Growth Forecast for Businesses 2025–2029

November 11, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Octreotide Market?

The octreotide market has observed steady expansion over recent years. It is anticipated to increase from $2.45 billion in 2024 to $2.56 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.5%. The historical growth of this market can be linked to the rising occurrence of acromegaly, a greater prevalence of hormonal disorders, increasing recognition of the importance of early diagnosis, advancements in healthcare infrastructure, and an escalation in cancer diagnoses.

The octreotide market is projected to experience consistent expansion over the upcoming years. This market is predicted to reach a value of $3.11 billion by 2029, expanding at a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this growth during the forecast period include a growing elderly population, enhanced awareness and prompt diagnosis, a rise in instances of severe diarrhea, increased expenditure on healthcare, and an expanding array of new drug candidates. Key trends anticipated for the forecast period encompass the introduction of new drugs, various product launches, regulatory product approvals, advancements in technology, and the expansion into new markets.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21234&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Octreotide Industry?

The future expansion of the octreotide market is expected to be propelled by the increasing rates of cancer. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells within the body. The rise in cancer rates is largely attributable to aging populations, environmental factors, lifestyle choices, and improved detection methods. Octreotide assists in countering these rising cancer rates by inhibiting tumor growth, controlling hormone-related cancers, and alleviating associated symptoms. For instance, in May 2024, according to reports published by the National Cancer Institute (NCI), a US-based government agency, there were nearly 20 million new cancer cases and 9.7 million deaths worldwide, with projections for 2040 rising to 29.9 million cases and 15.3 million deaths. Therefore, increasing rates of cancer are driving the growth of the octreotide market.

What Are The Key Segments In The Octreotide Market?

The octreotide market covered in this report is segmented –

1) By Type: Octreotide Acetate, Octreotide, Octreotide Chloride, Octreotide Hydrochloride, Indium In-111 Octreotide

2) By Form: Injection, Powder, Microspheres

3) By Indications: Diarrhea, Acromegaly, Other Indications

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-user: Pharmaceutical, Clinical Research

Subsegments:

1) By Octreotide Acetate: Injectable Formulation, Depot Injectable Formulation

2) By Octreotide: Injectable Formulation, Oral Formulation

3) By Octreotide Chloride: Injectable Formulation, Lyophilized Powder

4) By Octreotide Hydrochloride: Injectable Formulation, Lyophilized Powder

5) By Indium In-111 Octreotide: Diagnostic Radiopharmaceutical Formulation, Therapeutic Radiopharmaceutical Formulation

Which Ongoing Trends Are Expected To Shape The Octreotide Market Outlook?

Leading companies in the octreotide market are concentrating on developing innovative products, such as injectable suspensions, to enhance patient adherence and convenience. Injectable suspensions are fast-acting medications administered via injection, enabling quicker absorption into the bloodstream and bypassing the digestive system for a faster onset of action. For instance, in October 2024, Teva Pharmaceuticals, an Israel-based pharmaceutical company, launched the generic version of Sandostatin LAR Depot (octreotide acetate for injectable suspension), which is designed to be injected for rapid absorption into the bloodstream. Octreotide is a synthetic analog of the natural hormone somatostatin and is primarily employed to manage conditions like acromegaly, carcinoid syndrome, and VIP-secreting tumors. This injectable delivery method allows for a more rapid onset of action compared to traditional oral tablets, thereby making it simpler for patients to follow their treatment plans.

Who Are The Major Companies Operating In The Octreotide Market?

Major companies operating in the octreotide market are Novartis International AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Ipsen S.A., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Bachem Holding AG, Chemi S.p.A., LGM Pharma LLC, Hainan Shuangcheng Pharmaceuticals Co. Ltd., USV Private Limited, ChemWerth Inc., Shanghai Soho-Yiming Pharmaceuticals Co. Ltd., Neiss Labs Private Limited, Samarth Life Sciences Private Limited, TAPI Technology & API Services, BCN Peptides S.A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/octreotide-global-market-report

What Are The Key Regional Factors Influencing The Octreotide Market Growth?

North America was the largest region in the octreotide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the octreotide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Octreotide Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21234&type=smp

Browse Through More Reports Similar to the Global Octreotide Market 2025, By The Business Research Company

Antithyroid Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antithyroid-drugs-global-market-report

Thyroid Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

Anti Thyroid Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795